CliffBio
small molecule

E.E.S. 400

ERYTHROMYCIN ETHYLSUCCINATE

Loss of exclusivity—loss of exclusivity
CompanyARBOR PHARMACEUTICALS LLC

Drug detail

Brand nameE.E.S. 400
Active ingredientERYTHROMYCIN ETHYLSUCCINATE
StrengthEQ 400MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from ARBOR PHARMACEUTICALS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

E.E.S. 400 patent cliff — loss of exclusivity — | CliffBio